We are live on ! Find out more
SLDB icon

Solid Biosciences
SLDB

76 hedge funds and large institutions have $878M invested in Solid Biosciences in 2018 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 32 increasing their positions, 12 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

167% more repeat investments, than reductions

Existing positions increased: 32 | Existing positions reduced: 12

150% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 8

42% more capital invested

Capital invested by funds: $616M → $878M (+$262M)

25% more funds holding in top 10

Funds holding in top 10: 4 → 5 (+1)

19% more funds holding

Funds holding: 64 → 76 (+12)

0.24% more ownership

Funds ownership: 3.26% → 3.5% (+0.24%)

Holders
76
Holders Change
+12
Holders Change %
+18.75%
% of All Funds
1.74%
Holding in Top 10
5
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+25%
% of All Funds
0.11%
New
20
Increased
32
Reduced
12
Closed
8
Calls
$231K
Puts
–
Net Calls
+$231K
Net Calls Change
+$231K

Top Buyers

Rank Fund Capital Flow
1
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$21.6M
2
PHS
PFM Health Sciences
California
+$13.8M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$12.7M
4
FCM
Farallon Capital Management
California
+$12.4M
5
Fidelity Investments
Fidelity Investments
Massachusetts
+$10.8M

Top Sellers

Rank Fund Capital Flow
1
RI
RTW Investments
New York
-$17.3M
2
DM
Deerfield Management
New York
-$6.39M
3
JP Morgan Chase
JP Morgan Chase
New York
-$5.75M
4
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$4.61M
5
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$4.29M
Name Holding Trade Value Shares
Change 		Change in
Stake
Charles Schwab
26
Charles Schwab
California
$3.49M +$1.5M +2,393 +94%
EU
27
Emory University
Georgia
$3.29M +$2.92M +4,652 New
HCM
28
Highline Capital Management
New York
$2.6M +$109K +173 +5%
UBS Group
29
UBS Group
Switzerland
$2.26M +$316K +503 +19%
Morgan Stanley
30
Morgan Stanley
New York
$2.13M +$978K +1,557 +107%
Bank of New York Mellon
31
Bank of New York Mellon
New York
$1.97M +$414K +659 +31%
D.E. Shaw & Co
32
D.E. Shaw & Co
New York
$1.63M -$734K -1,168 -34%
Deutsche Bank
33
Deutsche Bank
Germany
$1.31M +$413K +658 +55%
Hudson Bay Capital Management
34
Hudson Bay Capital Management
Connecticut
$1.18M -$418K -666 -29%
ARTA
35
A.R.T. Advisors
New York
$1.09M +$970K +1,544 New
TCIM
36
TIAA CREF Investment Management
New York
$1.06M +$105K +167 +13%
AllianceBernstein
37
AllianceBernstein
Tennessee
$1.04M +$193K +307 +26%
TA
38
Teachers Advisors
New York
$1.02M +$114K +181 +14%
Squarepoint
39
Squarepoint
New York
$952K +$845K +1,345 New
California State Teachers Retirement System (CalSTRS)
40
California State Teachers Retirement System (CalSTRS)
California
$880K +$197K +314 +34%
OAM
41
Oxford Asset Management
United Kingdom
$602K +$542K +862 New
FAM
42
Fred Alger Management
New York
$566K +$503K +800 New
AH
43
Aviva Holdings
Bahamas
$542K – – –
BCM
44
BlueCrest Capital Management
Jersey
$519K +$461K +733 New
New York State Common Retirement Fund
45
New York State Common Retirement Fund
New York
$495K – – –
RhumbLine Advisers
46
RhumbLine Advisers
Massachusetts
$468K +$55.9K +89 +16%
State of Wisconsin Investment Board
47
State of Wisconsin Investment Board
Wisconsin
$448K +$398K +633 New
Wells Fargo
48
Wells Fargo
California
$389K +$163K +260 +90%
MC
49
Matisse Capital
Oregon
$382K +$339K +540 New
AIG
50
American International Group
New York
$381K +$90.5K +144 +36%
1
2
3 4

SLDB Hedge Fund Activity: Q3 2018 in Review

76 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Solid Biosciences (SLDB) for Q3 2018, worth a combined $878M — up 42% from $616M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new SLDB positions and 8 closed out — a net gain of 12 holders — while 32 added to existing stakes and 12 trimmed.

The largest buyer was Janus Henderson Group, opening a new position worth an estimated $21.6M. The largest seller was RTW Investments, cutting an estimated $17.3M.

  • 76 institutional investors held Solid Biosciences (SLDB) as of Q3 2018, up from 64 in Q2 2018.
  • Funds reported $878M of Solid Biosciences stock for Q3 2018, up 42% quarter-over-quarter.
  • 20 funds opened new Solid Biosciences positions in Q3 2018 and 8 closed out, a net change of +12 holders.
  • The largest Solid Biosciences buyer in Q3 2018 was Janus Henderson Group, an estimated $21.6M added.
  • The largest Solid Biosciences seller in Q3 2018 was RTW Investments, an estimated $17.3M sold.

Based on aggregated 13F filings for Q3 2018.